Dorval Allison (CIK 1625110) reported 5 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2025-07-28). Recent activity: Sell VERV (13,280 shares), Sell PBYI (11,610 shares), Buy PBYI (27,000 shares), Buy VERV (11,250 shares), Sell VERV (3,350 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-28 | Verve Therapeutics, Inc. (VERV) | Chief Financial Officer | Sell | 13,280 | $0 |
| 2025-06-17 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Director | Sell | 11,610 | $39,474 |
| 2025-06-13 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Director | Buy | 27,000 | $0 |
| 2025-04-03 | Verve Therapeutics, Inc. (VERV) | Chief Financial Officer | Buy | 11,250 | $0 |
| 2025-04-03 | Verve Therapeutics, Inc. (VERV) | Chief Financial Officer | Sell | 3,350 | $13,902 |
Source: SEC Form 4 filings · as of 2025-07-28